Digital Pathology Market is expected to garner $1,052 million by 2022. Digital pathology is an emerging technology in the field of pathology. In the modern methodology, the glass slides containing specimen samples are converted into digital images for easy viewing, analysis, storage, and management of the collected data. This is enabled in part by virtual microscopy, a technology that enables successful image posting and transmission over a connected network. The data-rich image forms the base for maintenance of electronic health records of the patient populace and compile the distributed information to build a central database. The advancements in digital pathology is expected to take the conventional pathology to a more advanced level. Digitalization of pathology has led to the automation of the tests during diagnosis, thus saving cost and efforts. For example, now a single digital instrument can perform those tests that were previously performed using five instruments by pathologists. The net effect has been observed in the form of impressive cost-reduction in total cost of diagnostic procedures and services.
1.1 Company Overview
1.2 Company Snapshot
1.3 Operating Business Segment
1.4 Business Performance
1.5 Key Strategic moves and Development
TABLE 1. VISIOPHARM - COMPANY SNAPSHOT
TABLE 2. VISIOPHARM - OPERATING SEGMENTS
FIG. 1. VISIOPHARM - SWOT ANALYSIS
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of the scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save the time of readers